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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
nature publishing group
HCN channels  
as pacemakers  
of ureter peristalsis
Ureteric peristalsis is an ordered 
and stereotyped process that moves 
the urine to the bladder. Disordered 
peristalsis often causes functional 
obstruction. Ureteric smooth muscle 
contraction needs to be synchronized, 
and the electric wave has to progress 
downward. In many such systems of 
ordered excitability, there is often a 
pacemaker, such as, most obviously 
and classically, in the heart. Pacemaker 
channels have characteristic electro-
physiological behavior, such as cation 
(including calcium) selectivity and acti-
vation by hyperpolarizating voltages 
and cyclic nucleotides. In this issue, 
Hurtado et al. demonstrate the pres-
ence of one these channels in a region 
of the kidney that exists at the junc-
tion of the pelvis. Using RNA analysis, 
they found that this channel belongs 
to the hyperpolarization-activated 
cation (HCN) family. Inhibitors of this 
channel, HCN3, randomized electrical 
activity, markedly inhibiting peristalsis. 
See page 500.
IgA nephropathy  
and MMF
The treatment of IgA nephropathy 
remains a subject of active investiga-
tion. As they report in this issue, Tang 
et al. studied IgA nephropathy patients 
with established disease who were being 
treated by angiotensin blockade. Half of 
the 40 patients received mycophenolate 
mofetil (MMF). After 6 years of treat-
ment, fewer patients in the MMF-treated 
group required dialysis. Further, the 
decline in estimated glomerular filtra-
tion rate was slower in the MMF-treated 
group than in the group on traditional 
treatment. Similarly, proteinuria was 
lower in the treated group. The patients 
did not have extensive lesions at the 
onset of the randomization, and these 
results suggest that MMF could produce 
significant improvement in the outcome 
of such patients. See page 543.
IL-6 and mortality
There now is overwhelming evidence 
that inflammation is a risk factor for 
a number of cardiovascular diseases, 
including those associated with renal 
failure. Barreto et al. measured the 
plasma interleukin-6 (IL-6) levels in 
patients with chronic kidney disease. 
They found that the plasma levels of IL-6 
were correlated, as expected, with other 
inflammatory markers such as C-reac-
tive protein and also with other impor-
tant predictors of mortality such as 
plasma albumin. However, there was no 
correlation with aortic calcification or 
arterial stiffness. Long-term follow-up 
showed that IL-6 was a better predictor 
of mortality than was C-reactive pro-
tein. While correlation is not causation, 
IL-6 is a known inflammatory mediator; 
hence, it is important to design future 
studies to evaluate whether reduction of 
the plasma levels is associated with an 
improved outcome. See page 550.
